Regeneron beats quarterly sales on COVID-19 drug demand
Go back to Regeneron beats quarterly sales on COVID-19 drug demand| Regeneron (NASDAQ: REGN) | Delayed: 617.60 +5.10 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $612.50 | 52 Week High | $592.36 | |||
| Open | $607.92 | 52 Week Low | $325.35 | |||
| Day High | $621.79 | P/E | 162.10 | |||
| Day Low | $607.92 | EPS | $3.81 | |||
| Volume | 412,119 | |||||

